Page last updated: 2024-10-30

memantine and Cancer of Prostate

memantine has been researched along with Cancer of Prostate in 2 studies

Research Excerpts

ExcerptRelevanceReference
"Memantine is an FDA-approved Alzheimer's drug."1.48Memantine induces apoptosis and inhibits cell cycle progression in LNCaP prostate cancer cells. ( Albayrak, G; Bilen, CY; Dikmen, AU; Konac, E, 2018)
"Of 18 benign prostatic hyperplasia (BPH) specimens, none had stromal NMDAr staining, but 2 had low and 1 had high epithelial NMDAr immunoreactivity."1.33N-methyl-D-aspartate receptor in human prostate cancer. ( Abdul, M; Hoosein, N, 2005)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Albayrak, G1
Konac, E1
Dikmen, AU1
Bilen, CY1
Abdul, M1
Hoosein, N1

Other Studies

2 other studies available for memantine and Cancer of Prostate

ArticleYear
Memantine induces apoptosis and inhibits cell cycle progression in LNCaP prostate cancer cells.
    Human & experimental toxicology, 2018, Volume: 37, Issue:9

    Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Cell Cycle; Cell Cycle Proteins; Ce

2018
N-methyl-D-aspartate receptor in human prostate cancer.
    The Journal of membrane biology, 2005, Volume: 205, Issue:3

    Topics: Breast; Cell Line; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Cysteine; Dizocilpine Ma

2005